The field of hematology has seen remarkable advancements, particularly in the management of conditions like thrombocytopenia, where low platelet counts pose significant health risks. Lusutrombopag (CAS 1110766-97-6) stands out as a key therapeutic agent in this area. As a specialized manufacturer of pharmaceutical intermediates, NINGBO INNO PHARMCHEM is committed to supporting medical progress by providing high-quality Lusutrombopag.

Lusutrombopag functions as a thrombopoietin (TPO) receptor agonist. Its mechanism of action is finely tuned to stimulate megakaryopoiesis, the process by which platelets are produced. By activating the TPO receptor, it effectively signals the bone marrow to increase platelet production. This makes it a critical pharmaceutical chemical for patients experiencing medically induced or disease-related thrombocytopenia. Its oral bioavailability also enhances patient compliance and ease of administration, a significant factor in therapeutic success.

The primary application for Lusutrombopag currently lies in treating thrombocytopenia associated with chronic liver disease (CLD), particularly for patients who require invasive procedures. The ability of this compound to reliably increase platelet counts before surgery can drastically reduce the risk of complications. For pharmaceutical companies and research institutions looking to purchase Lusutrombopag, understanding these applications ensures they are acquiring the correct compound for their specific needs. We serve as a reliable manufacturer and supplier for such critical APIs.

NINGBO INNO PHARMCHEM provides Lusutrombopag in pharmaceutical grade, ensuring the highest standards of purity and efficacy. Our role as a manufacturer in China allows us to offer competitive pricing, making advanced therapies more accessible. Whether you are a research scientist exploring new treatment protocols or a procurement manager securing raw materials for drug manufacturing, our consistent supply and quality assurance are designed to meet your demands. We invite you to inquire about our pricing and availability for Lusutrombopag.

The development of targeted therapies like Lusutrombopag represents a significant step forward in managing hematological disorders. By sourcing this essential pharmaceutical intermediate from a trusted supplier like NINGBO INNO PHARMCHEM, you are investing in the quality and reliability that underpin successful pharmaceutical products and groundbreaking research.